[The cost of an HIV patient. Lack of funds for optimal treatment?].
Many patients with HIV--a group in urgent need of effective health care measures--are extremely worried by current discussions on budgeting, fearing, as daily practice shows, restrictions on vitally indicated services. The present article describes the results of a recent health economics study of the direct and indirect costs generated by HIV infection.
Stoll
M
M
Zentrum Innere Medizin, Medizinischen Hochschule Hannover. stoll.matthias@mh-hannover.de
Schulte
E
E
Claes
C
C
Graf von der Schulenburg
J M
JM
Schmidt
R E
RE
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics*; D003363:Cost Control / Q000639:trends; D005544:Forecasting; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics*; D006301:Health Services Needs and Demand / Q000191:economics*; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D011785:Quality Assurance, Health Care / Q000191:economics*
D019380:Anti-HIV Agents